Lung Cancer Clinical Trials in Pavia
2 recruitingPavia, Italy
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Lung CancerEGFRNSCLC, Stage IB-IIIA+5 more
Taiho Oncology, Inc.360 enrolled214 locationsNCT07128199
Recruiting
Ambispective Registry of Patients Affected by Lung Cancer
Lung Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia1,500 enrolled1 locationNCT07274163